Cypress Bioscience, Inc. to Present at Baird's 2010 Health Care Conference
September 15 2010 - 6:30AM
Marketwired
Cypress Bioscience, Inc. (NASDAQ: CYPB) today
announced that Jay D. Kranzler, MD, PhD, its Chairman of the Board
and Chief Executive Officer, will present at the Baird 2010 Health
Care Conference today, September 15, 2010.
The Baird conference is being held at the St. Regis New York
Hotel in New York, NY. Dr. Kranzler is scheduled to present on
Wednesday, September 15th at 11:00 am Eastern Time. The audio
broadcast of this presentation can be accessed at
http://www.wsw.com/webcast/baird16/cypb/.
A replay of the presentation will be available at the same web
address as well as on Cypress' website,
http://www.cypressbio.com/events.php.
About Cypress Bioscience Cypress
Bioscience is a pharmaceutical company dedicated to the development
of innovative drugs targeting large unmet medical needs for
patients suffering from a variety of disorders of the central
nervous system. Since 1999, Cypress has received multiple FDA
approvals, including for Prosorba™, a medical device for rheumatoid
arthritis, and Savella® (milnacipran HCl), for fibromyalgia. The
Company focuses on generating stockholder value by reaching
clinical development milestones as quickly and efficiently as
possible. Cypress' currently marketed products include Savella and
the Avise PG(SM) and Avise MCV(SM) therapeutic monitoring,
diagnostic and prognostic testing services for rheumatoid
arthritis. Development-stage assets include CYP-1020 for cognitive
impairment in schizophrenia, Staccato® nicotine for smoking
cessation, intranasal carbetocin for autism, and AVISE-SLE(SM), a
lupus diagnostic testing service. More information on Cypress and
its products and development assets is available at
http://www.cypressbio.com/.
For more information about Cypress, please visit the Company's
website at www.cypressbio.com.
For additional information please contact Mary Gieson
Investor Relations Manager (858) 452-2323 Email Contact
Cypress Bioscience (NASDAQ:CYPB)
Historical Stock Chart
From Jun 2024 to Jul 2024
Cypress Bioscience (NASDAQ:CYPB)
Historical Stock Chart
From Jul 2023 to Jul 2024